Clinical Dermatology During COVID-19 Webinar Scheduled for April 30


The free webinar, "Derm Clinical Updates: Keeping Up with COVID-19," will feature a four-expert panel fielding topics on therapies, immunocompromised patients, telemedicine, surgery, and more.

Few specialists may face a greater array of questions surrounding their patients’ risks, standing of care, and how current coronavirus 2019 (COVID-19) therapy candidates may affect them than dermatologists.

From telemedicine to at-risk patients, from reprioritizing personnel to limiting invasive procedures, every dermatologist is practicing in an unfamiliar and uncertain space during the pandemic. It benefits them as much to learn what they need to know about COVID-19, as it does to learn what doesn’t affect their practice or patients.

A panel of experts are teaming up with HCPLive® to inform their colleagues on everything COVID-19—inside and out of dermatology.

HCPLive is hosting Derm Clinical Updates: Keeping Up with COVID-19, an interactive webinar for caregivers in dermatology.

Featured speakers include:

  • Brad Glick, DO, FAAD, Board-Certified Dermatologist and Dermatologic Surgeon with the Glick Skin Institute
  • Joel Gelfand, MD, MSCE, Professor of Dermatology and Epidemiology at the University of Pennsylvania’s Perelman School of Medicine
  • M. Laurin Council, MD, Associate Professor of Dermatology at Washington University School of Medicine
  • Adam Friedman, Professor & Interim Chair of Dermatology at The George Washington University School of Medicine and Health Sciences

The webinar will take place Thursday, April 30, at 7 pm EDT. Topics include the management of immunocompromised patients during COVID-19, maintaining biologic care for dermatologic conditions, what dermatologists should know from the most recent COVID-19 clinical trials, the do’s and don’ts of telemedicine practice, and how to prioritize surgery and aesthetic care during the pandemic.

Registration details are available here.

As part of our commitment to providing education to healthcare and industry sciences professionals during the COVID-19 pandemic, attendance at this webinar is free of charge. However, if you’d like to make a donation to help first responders through the New Jersey Pandemic Relief Fund, MJH Life Sciences™ will match all contributions. To make a donation, please click “donate” below and complete the requested information.

Recent Videos
Discussing Post-Hoc Data on Ruxolitinib for Nonsegmental Vitiligo, with David Rosmarin, MD
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
© 2024 MJH Life Sciences

All rights reserved.